Date:29-Apr-2024  Time: 7:51 AM
 
 
        
Tatva Chintan Pharma Chem Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales86.0792.57106.11119.41
Other Income1.210.761.020.78
Total Income87.2893.33107.12120.19
Total Expenditure 73.7671.8386.49107.59
Operating Profit13.5221.5020.6312.60
Interest0.383.012.903.18
Gross Profit13.1518.4817.739.42
Depreciation6.586.786.012.53
Tax1.321.862.04-4.46
Deferred Tax0.591.651.43-4.80
Reported Profit After Tax4.658.208.2516.15
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com